Skip to main content
Have a personal or library account? Click to login
Nimbolide Reduces Inflammation and Oxidative Stress to Inhibit Disease Progression in Septic Acute Kidney Injury Mice Cover

Nimbolide Reduces Inflammation and Oxidative Stress to Inhibit Disease Progression in Septic Acute Kidney Injury Mice

By: ,   and    
Open Access
|Aug 2026

References

  1. Annaldas S, Saifi MA, Khurana A et al. (2019) Nimbolide ameliorates unilateral ureteral obstruction-induced renal fibrosis by inhibition of TGF-β and EMT/Slug signalling. Mol Immunol 112:247–255. https://doi.org/10.1016/j.molimm.2019.06.003
  2. Ba J, Lin Y, Zhang J et al. (2025) Nimbolide targeting SIRT1 protects against acetaminophen-induced acute liver injury by regulating oxidative stress and endoplasmic reticulum stress. Pharmacol Res Perspect 13:e70120. https://doi.org/10.1002/prp2.70120
  3. Jiang J, Hu B, Chung CS et al. (2020) SHP2 inhibitor PHPS1 ameliorates acute kidney injury by Erk1/2-STAT3 signaling in a combined murine hemorrhage followed by septic challenge model. Mol Med 26:89. https://doi.org/10.1186/s10020-020-00210-1
  4. Li N, Lin G, Zhang H et al. (2023) Lyn attenuates sepsis-associated acute kidney injury by inhibition of phospho-STAT3 and apoptosis. Biochem Pharmacol 211:115523. https://doi.org/10.1016/j.bcp.2023.115523
  5. Li H, Ren Q, Hu Y et al. (2024) SKLB023 protects against inflammation and apoptosis in sepsis-associated acute kidney injury via the inhibition of Toll-like receptor 4 signaling. Int Immunopharmacol 139:112668. https://doi.org/10.1016/j.intimp.2024.112668
  6. Liu AB, Tan B, Yang P et al. (2024) The role of inflammatory response and metabolic reprogramming in sepsis-associated acute kidney injury: Mechanistic insights and therapeutic potential. Front Immunol 15:1487576. https://doi.org/10.3389/fimmu.2024.1487576
  7. Lou Y, Shi H, Sha N et al. (2025) Ursodeoxycholic acid protects against sepsis-induced acute kidney injury by activating Nrf2/HO-1 and inhibiting NF-κB pathway. BMC Nephrol 26:45. https://doi.org/10.1186/s12882-025-03977-9
  8. Ma Y, Xu S, Meng J et al. (2022) Protective effect of nimbolide against streptozotocin induced gestational diabetes mellitus in rats via alteration of inflammatory reaction, oxidative stress, and gut microbiota. Environ Toxicol 37:1382–1393. https://doi.org/10.1002/tox.23491
  9. Mou L, Yang L, Hou S et al. (2023) Structure-activity relationship studies of 2,4,5-trisubstituted pyrimidine derivatives leading to the identification of a novel and potent sirtuin 5 inhibitor against sepsis-associated acute kidney injury. J Med Chem 66: 11517–11535. https://doi.org/10.1021/acs.jmedchem.3c01031
  10. Pooladanda V, Thatikonda S, Bale S et al. (2019) Nimbolide protects against endotoxin-induced acute respiratory distress syndrome by inhibiting TNF-α mediated NF-κB and HDAC-3 nuclear translocation. Cell Death Dis 10:81. https://doi.org/10.1038/s41419-018-1247-9
  11. Ren Q, Guo F, Tao S et al. (2020) Flavonoid fisetin alleviates kidney inflammation and apoptosis via inhibiting Src-mediated NF-κB p65 and MAPK signaling pathways in septic AKI mice. Biomed Pharmacother 122:109772. https://doi.org/10.1016/j.biopha.2019.109772
  12. Şahin N, Bora ES, Çınaroğlu OS et al. (2025) Rho-associated kinase inhibitor fasudil protects from sepsis-induced acute kidney injury in rat via suppressing STAT-3 and NLRP-3 pathway. Curr Issues Mol Biol 47:340. https://doi.org/10.3390/cimb47050340
  13. Senousy SR, Ahmed AF, Abdelhafeez DA et al. (2022) Alpha-chymotrypsin protects against acute lung, kidney, and liver injuries and increases survival in CLP-induced sepsis in rats through inhibition of TLR4/NF-κB pathway. Drug Des Devel Ther 16:3023–3039. https://doi.org/10.2147/DDDT.S370460
  14. Shu X, Hu Y, Huang C et al. (2021) Nimbolide ameliorates the streptozotocin-induced diabetic retinopathy in rats through the inhibition of TLR4/NF-κB signaling pathway. Saudi J Biol Sci 28:4255–4262. https://doi.org/10.1016/j.sjbs.2021.06.039
  15. Teng Y, Huang Y, Yu H et al. (2023) Nimbolide targeting SIRT1 mitigates intervertebral disc degeneration by reprogramming cholesterol metabolism and inhibiting inflammatory signaling. Acta Pharm Sin B 13:2269–2280. https://doi.org/10.1016/j.apsb.2023.02.018
  16. Wang X, Li J, Yu B et al. (2026) Nimbolide inhibits NLRP3 inflammasome activation via blocking NEK7-NLRP3 interaction and alleviates sepsis-induced lung injury. Int Immunopharmacol 168(Pt 2):115954. https://doi.org/10.1016/j.intimp.2025.115954
  17. Wang HW, Wu MM, Zhu MM et al. (2025) Growth differentiation factor 11 attenuates sepsis-associated acute kidney injury by reducing inflammation and coagulation via PGC-1α/Nrf2 activation. Cell Mol Biol Lett 30:102. https://doi.org/10.1186/s11658-025-00762-2
  18. Xia YM, Guan YQ, Liang JF et al. (2024) TAK-242 improves sepsis-associated acute kidney injury in rats by inhibiting the TLR4/NF-κB signaling pathway. Ren Fail 46:2313176. https://doi.org/10.1080/0886022X.2024.2313176
  19. Zhang R, Su K, Yang L et al. (2023) Design, synthesis, and biological evaluation of novel P2X7 receptor antagonists for the treatment of septic acute kidney injury. J Med Chem 66:11365–11389. https://doi.org/10.1021/acs.jmedchem.3c00837
Language: English
Submitted on: Mar 31, 2026
Accepted on: Jul 10, 2026
Published on: Aug 22, 2026
Published by: Hirszfeld Institute of Immunology and Experimental Therapy
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2026 Yihua Yu, Yangling Li, Ying Gong, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.